UNSPSC 51294414: Vilazodone

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S239O2OOV3. European Medicines Agency schedules Vilazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32166. Vilazodone generally arises in the molecular formula C26H27N5O2. The term VILAZODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 1, 2001, list 45.) Most nations schedule vilazodone under HS 29349990 and SITC 51579.

As of Q4 2014, VILAZODONE remains the US FDA Preferred Term for this commodity. Vilazodone bears US NLM identifiers UMLS ID C1530072 and NCI Concept Code C90716. SMILES: C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.

UNSPSC 51294414 Vilazodone is a Commodity code nominally identifying a single antidepressant pharmaceutical product, but recent state and local procurement activity tagged under this code shows little direct alignment with vilazodone procurement itself. The three most recent opportunities involve broader pharmaceutical and drug-response product categories: naloxone and drug deactivation systems for community health; direct-to-manufacturer prescription programs for state pharmacy benefits; and multi-source generic pharmaceuticals and OTC products through cooperative purchasing. State and local governments use codes in this family to procure medications, medical supplies, and pharmaceutical services through health departments, HHS agencies, and cooperative purchasing alliances, but the specific commodity—vilazodone—does not appear explicitly in any of the recent solicitations reviewed. The issuing bodies span state health agencies, county health departments, and multistate cooperative purchasing organizations.

Recent activity centers on three distinct procurement types across Texas, Minnesota, Florida, and participating cooperative-purchasing jurisdictions. Seminole County, Florida issued IFB 60459723LAS (response deadline July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and FEMA compliance required. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs for state pharmacy benefits, soliciting vendor capabilities rather than binding awards. The Minnesota Department of Administration issued RFP S1070000015802 (response deadline March 26, 2026) through MMCAP to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, including Oregon, with vendor proposals evaluated 75 percent on price competitiveness and effective July 1, 2026. The code shows little recent direct demand for vilazodone specifically and warrants verification that opportunities tagged under this commodity align with your product scope before pursuing.